Cabaletta Bio, Inc. (CABA) Q4 2024 Annual Earnings
CABA·Reported March 31, 2025·Before market open
Cabaletta Bio, Inc. reported Q4 2024 revenue of $1.6M. Diluted EPS came in at $-0.65.
Revenue
$1.6M
Diluted EPS
$-0.65met estimate
Consensus: $-0.65
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Cabaletta Bio, Inc.'s Q4 2024 earnings report.
Cabaletta Bio, Inc. (CABA) reported Q4 2024 earnings on March 31, 2025 before market open.
Cabaletta Bio, Inc. reported revenue of $1.6M and diluted EPS of $-0.65 for Q4 2024.
EPS beat the consensus estimate of $-0.65 by $0.00.
You can read the 10-K periodic report (0000950170-25-047201) directly on SEC EDGAR. The filing index links above go to sec.gov.